| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |